Buprenorphine possesses many unique attributes that make it a practical agent for adults
and adolescents with opioid use disorder (OUD) and/or acute or chronic pain. Sublingual …

Buprenorphine induction for treating opioid use disorder is being implemented in
emergency care. During this era of high-potency synthetic opioid use, novel and divergent …

Importance Opioid misuse and opioid use disorder (OUD) are important comorbidities in
people with advanced cancer and cancer-related pain, but there is a lack of consensus on …

The prescription of generic drugs represents one of the main cost-containment strategies of
health systems, aimed at reducing pharmaceutical expenditure. In this context, most …

In 2022, the CDC revised its and encourage clinicians to weight the risks versus harms of
continued therapy and empathetically engage patients in patient-centered discussions …

Background Patterns of opioid use vary, including prescribed use without aberrancy, limited
aberrant use, and potential opioid use disorder (OUD). In clinical practice, similar opioid …

Pain and opioid use disorder (OUD) are inextricably linked, as the former can be a risk factor
for the development of the latter, and over a third of persons with OUD suffer concomitant …

Current research indicates that tapering opioids may improve pain and function in patients
with chronic noncancer pain. However, gaps in the literature remain regarding the choice of …

Due to the prevalence of chronic pain and high-impact chronic pain in the US, a significant
percentage of the population is prescribed opioids for pain management. However, opioid …

Objective To review interventions to reduce long term opioid treatment in people with
chronic non-cancer pain, considering efficacy on dose reduction and discontinuation, pain …